Dr. Steven Messe served as one of lead investigators for a randomized trial testing the usefulness of embolic protection devices to reduce stroke in aortic valve replacement. Read the publication in JAMA:
Glenn Konsky, DO
Glenn attended medical school at New York College of Osteopathic Medicine, and completed his residency in neurology at the University of Maryland.
Chris Renner, MD
Chris attended medical school at Drexel University, and completed his residency in neurology at Rutgers University-Robert Wood Johnson Medical School.
James Siegler, MD
Jim attended medical school at Tulane University, and completed his residency in neurology here at the University of Pennsylvania.
At the European Organization Stroke Conference on May 16, 2017, Dr. Scott Kasner, co-PI of the REDUCE trial, presented the results of the study.
Click below to watch a video interview reviewing the trial findings.
We are pleased to announce that Sean Spangler, MS, has joined our team as a Clinical Research Coordinator. Welcome aboard!
Dr. Steven Messe is interviewed about the recent AAN guideline statement on PFO closure in a podcast sponsored by the journal Neurology. Click here to listen.
Brett Cucchiara, MD was interviewed for an UpToDate podcast on the early benefit of antiplatelet therapy after TIA or ischemic stroke. You can find the podcast here.